AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tacmute 0.1% Cream

Prescription Icon
Prescription Required

Marketer

Alter Ego Pharmaceuticals

Salt Composition

Tacrolimus (0.1% w/w)

Overview Tacmute 0.1% Cream

Dermacalm 0.1% Cream effectively manages eczema symptoms (atopic dermatitis) by modulating the immune response responsible for skin inflammation (redness and swelling). This reduces itching and improves rash appearance in atopic dermatitis. Apply Dermacalm 0.1% Cream topically, two to four times daily to affected areas, or as directed by your physician. Gently and evenly distribute the cream until fully absorbed. Avoid overuse and occlusive dressings. Consult your doctor if symptoms don't improve within two weeks or worsen. Potential side effects include skin redness, headache, folliculitis, and local reactions such as burning, irritation, itching, and redness. Use during pregnancy or breastfeeding is generally discouraged unless deemed essential by a healthcare professional.

Primary Ingredients of Tacmute 0.1% Cream

No text provided. Please provide the text you wish me to rephrase.

Uses of Tacmute 0.1% Cream

Managing atopic dermatitis

Major Benefits of Tacmute 0.1% Cream:

Apply this medication only to the skin's surface. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application guidelines. Before applying, ensure the affected area is clean and dry. Wash your hands thoroughly afterward, except when the hands themselves are being treated.

Common Side effects of Tacmute 0.1% Cream:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacmute 0.1% Cream:

Apply this medication solely to the skin's surface. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application guidelines. Ensure the affected area is clean and dry before applying the cream. Wash your hands thoroughly afterward, unless the application site is on your hands.

How Tacmute 0.1% Cream works:

Tacmute 0.1% Cream, an immunosuppressive agent, reduces skin inflammation (redness and swelling) by modulating the activity of specific immune cells. This action alleviates itching and enhances the appearance of rashes associated with atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Tacmute 0.1% Cream during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Application of Tacmute 0.1% Cream while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Tacmute 0.1% Cream :

Should you forget a dose of Tacmute 0.1% Cream, apply it promptly. Nevertheless, if your next scheduled application is imminent, omit the missed dose and resume your usual dosing regimen.

Facts to Know About Tacmute 0.1% Cream

LabelValue
Type of Compound Large-ring lactone antibiotics
Potential for Dependence None.
Treatment Category Cancer-fighting medications
Mechanism of Action Drugs that suppress the immune system: Calcineurin inhibitor class

FAQs on Tacmute 0.1% Cream

Immunomodulatory Tacmute 0.1% Cream reduces immune system activity. This cream treats moderate to severe adult eczema (atopic dermatitis) unresponsive to steroids or those experiencing steroid side effects. Atopic dermatitis involves an overactive skin immune response causing inflammation, itching, redness, and dryness. Tacmute 0.1% Cream modifies this abnormal immune reaction, lessening skin inflammation and itching.
Topical application of Tacmute 0.1% Cream may induce localized skin reactions such as irritation, burning, and pruritus. These effects are typically mild to moderate and generally subside within seven days of treatment initiation. Erythema is frequently observed, accompanied by warmth, discomfort, paresthesia, and a possible rash at the application site. Treatment is associated with a heightened risk of folliculitis, herpes labialis, acne, and disseminated herpes simplex infections.
Tacmute 0.1% Cream offers a safe and effective short-term topical treatment for atopic dermatitis, exhibiting superior safety compared to other immunosuppressant medications. Minimal systemic absorption following cutaneous application results in fewer side effects than those observed with oral immunosuppressants.
Tacmute 0.1% Cream is not a controlled substance and does not present a risk of misuse. Controlled substances, by definition, have a potential for abuse, requiring authorization from both medical professionals and regulatory bodies.
Prolonged application of Tacmute 0.1% Cream has been associated with a heightened risk of lymphomas, a type of lymph node tumor. Limited research indicates a correlation between the use of Tacmute 0.1% Cream or comparable therapies and the development of skin cancer or lymphoma in a small number of patients. Seek medical advice if Tacmute 0.1% Cream is needed for over six weeks, or if your eczema symptoms fail to improve or worsen despite treatment.
Tacmute 0.1% Cream is a non-steroidal medication that regulates immune system function. Primarily employed in eczema treatment, particularly atopic dermatitis, it offers the benefit of avoiding skin thinning or other adverse effects typically associated with steroids.
Tacmute 0.1% Cream
273
MRP 332
17% off